
Ageless
The New Science of Getting Older Without Getting Old
Failed to add items
Add to cart failed.
Add to wishlist failed.
Remove from wishlist failed.
Follow podcast failed
Unfollow podcast failed

2 credits with free trial
Buy Now for ₹531.00
No valid payment method on file.
We are sorry. We are not allowed to sell this product with the selected payment method
-
Narrated by:
-
Andrew Steele
-
Written by:
-
Andrew Steele
About this listen
Bloomsbury presents Ageless written and read by Andrew Steele.
'A stunner ... If you haven't got this book in your house, I don't know why' Chris Evans
'A startling wake-up call . . . Writing with the vim of a Bill Bryson and the technical knowledge of a scientist, Steele gives us a chance to grasp what's at stake' Independent
'An exhilarating journey . . . Steele is a superb guide' Telegraph
'A fascinating read with almost every page bursting with extraordinary facts . . . Read it now' Mail on Sunday
Ageless is a guide to the biggest issue we all face. Ageing – not cancer, not heart disease – is the world's leading cause of death and suffering. What would the world be like if we could cure it?
Living disease-free until the age of 100 is achievable within our lifetimes. In prose that is lucid and full of fascinating facts, Ageless introduces us to the cutting-edge research that is paving the way for this revolution. Computational biologist Andrew Steele explains what occurs biologically as we age, as well as practical ways we can slow down the process. He reveals how understanding the scientific implications of ageing could lead to the greatest discovery in the history of civilization – one that has the potential to improve billions of lives, save trillions of dollars, and transform the human condition.
Critic Reviews
"An absolute tour de force." (Aubrey de Grey, chief science officer, SENS Research Foundation)
"An immensely important book." (Professor Lewis Dartnell, author of Origins)
"This is an essential book for anyone interested in the fast-developing science of longevity." (Jim Mellon, chairman of Juvenescence)